PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Clinical trial

NCT07685808

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · PHASE 2 TRIAL

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with planned enrollment of 360 participants, currently recruiting, designed to assess safety, tolerability, and preliminary efficacy of olatorepatide in overweight/obesity without diabetes; no results are yet reported.

PreliminaryNCT07685808 Olatorepatide Overweight Or Obesity

Reported

Planned enrollment360

Study phasePhase 2

Primary outcome measure 1Occurrence of Treatment-Emergent Adverse Ev…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support